Essex Bio-Technology Limited
HKEX:1061.HK
Overview | Financials
Company Name | Essex Bio-Technology Limited |
Symbol | 1061.HK |
Currency | HKD |
Price | 2.64 |
Market Cap | 1,497,830,400 |
Dividend Yield | 2.79% |
52-week-range | 1.96 - 3.1 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Mia Je Ngiam B.Sc. |
Website | https://www.essexbio.com |
An error occurred while fetching data.
About Essex Bio-Technology Limited
Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD